Figure 4. The survival of mice bearing 32Dp210 T315I leukemia was significantly improved when treated with combination of HSP90 and JAK2 inhibitors.

(A) Survival curve of the mice experiment (**P<0.01). Drug treatment started at fourteen days after injecting 32Dp210 T315I cells into C3HJ mice via tail vein. (B) Comparison of the weight of spleens (left) and livers (right) from the four groups of mice.